Time course of oxidative stress, lesion and edema after intrastriatal injection of malonate in rat: Effect of α-phenyl-N-tert-butylnitrone

Fundamental and Clinical Pharmacology

Volumn 19, Issue 1, 2005, Pages 57-64

  Paucard, Alexia ^a   Besson, Valérie C ^a   Plotkine, Michel ^a   Margaill, Isabelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

phenyl N tert butylnitrone; Edema; Glutathione; Malonate

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONIC ACID; N TERT BUTYL ALPHA PHENYLNITRONE; NITRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STRIATE CORTEX; TIME;

ANIMALS; ANTIOXIDANTS; BRAIN EDEMA; CORPUS STRIATUM; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALE; MALONATES; NITROGEN OXIDES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 13444269233     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00297.x     Document Type: Article

References (36)

1. Love S., Barber R., Wilcock G.K. Neuronal death in brain infarcts in man. Neuropathol. Appl. Neurobiol. (2000) 26 55-66.
2. Lerouet D., Beray-Berthat V., Palmier B., Plotkine M., Margaill I. Changes in oxidative stress, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats. Brain Res. (2002) 958 1166-1175.
3. Kontos H.A., Povlishock J.T. Oxygen radicals in brain injury. Cent. Nerv. Syst. Trauma (1986) 3 257-263.
4. Mesenge C., Verrecchia C., Charriaut-Marlangue C., Margaill I., Boulu R.G., Plotkine M. Contribution of NO/ONOO- pathway to the deleterious effect of traumatic brain injury in mice. Drug Discov. Today (2000) 5 432-433.
5. Tyurin V.A., Tyurina Y.Y., Borisenko G.G. et al. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J. Neurochem. (2000) 75 2178-2189.
6. Giasson B.I., Ischiropoulos H., Lee V.M., Trojanowski J.Q. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic. Biol. Med. (2002) 32 1264-1275.
7. Perry G., Nunomura A., Hirai K. et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. (2002) 33 1475-1479.
8. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. (2000) 267 4904-4911.
9. Sies H. Glutathione and its role in cellular functions. Free Radic. Biol. Med. (1999) 27 916-921.
10. Webb J.L. Enzyme and metabolism inhibitors. Academic Press, New York, 1966.
11. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. (1993) 61 1147-1150.
12. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. (1998) 70 2406-2415.
13. Greene J.G., Greenamyre J.T. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. (1995) 64 430-436.
14. Ehrhart J., Zeevalk G.D. Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures. J. Neurochem. (2001) 77 1496-1507.
15. Zeevalk G.D., Manzino L., Hoppe J., Sonsalla P. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Eur. J. Pharmacol. (1997) 320 111-119.
16. Klivenyi P., Andreassen O.A., Ferrante R.J. et al. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J. Neurosci. (2000) 20 1-7.
17. Lecanu L., Margaill I., Boughali H., Cohen-Tenoudji B., Boulu R.G., Plotkine M. Deleterious Ca-independent NOS activity after oxidative stress in rat striatum. Neuroreport (1998) 9 559-563.
18. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Academic Press, Sydney, 1986.
19. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. (1969) 27 502-522.
20. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. (1980) 106 207-212.
21. Golanov E.V., Reis D.J. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab. (1995) 15 172-174.
22. Schulz J.B., Henshaw D.R., Siwek D. et al. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. (1995) 64 2239-2247.
23. Schulz J.B., Matthews R.T., Jenkins B.G. et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. (1995) 15 8419-8429.
24. Dringen R., Gutterer J.M., Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. (2000) 267 4912-4916.
25. Dickinson D.A., Forman H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. (2002) 64 1019-1026.
26. Murphy M.E., Scholich H., Sies H. Protection by glutathione and other thiol compounds against the loss of protein thiols and tocopherol homologs during microsomal lipid peroxidation. Eur. J. Biochem. (1992) 210 139-146.
27. Sian J., Dexter D.T., Lees A.J. et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. (1994) 36 348-355.
28. Schulz I.B., Weller M., Matthews R.T. et al. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ. (1998) 5 847-857.
29. Asanuma T., Ishibashi H., Konno A., Kon Y., Inanami O., Kuwabara M. Assessment of neuroprotective ability of a spin trap, alpha-phenyl-N-tert- butylnitrone, against malonate-induced ischemic injury of rat brain by apparent water diffusion coefficient mapping. Neurosci. Lett. (2002) 329 281-284.
30. Sen S., Phillis J.W. alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study. Free Radic. Res. Commun. (1993) 19 255-265.
31. Lancelot E., Revaud M.L., Boulu R.G., Plotkine M., Callebert J. alpha-Phenyl-N-tert-butylnitrone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation. Free Radic. Biol. Med. (1997) 23 1031-1034.
32. Chen G.M., Bray T.M., Janzen E.G., McCay P.B. Excretion, metabolism and tissue distribution of a spin trapping agent, alpha-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Radic. Res. Commun. (1990) 9 317-323.
33. Cheng H.Y., Liu T., Feuerstein G., Barone P.C. Distribution of spin-trapping compounds in rat blood and brain: in vivo microdialysis determination. Free Radic. Biol. Med. (1993) 14 243-250.
34. Hensley K., Pye Q.N., Maidt M.L. et al. Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J. Neurochem. (1998) 71 2549-2557.
35. Atamna H., Paler-Martinez A., Ames B.N. N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J. Biol. Chem. (2000) 275 6741-6748.
36. Schulz J.B., Matthews R.T., Jenkins B.G., Brar P., Beal M.F. Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. J. Cereb. Blood Flow Metab. (1995) 15 948-952.